Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2015 Nov 25;23(11):1794. doi: 10.1038/mt.2015.186

Corrigendum to “Disruption of KATP Channel Expression in Skeletal Muscle by Targeted Oligonucleotide Delivery Promotes Activity-linked Thermogenesis”

PMCID: PMC4817955  PMID: 26606662

Siva Rama Krishna Koganti, Zhiyong Zhu, Ekaterina Subbotina, Zhan Gao, Ana Sierra, Manuel Proenza, Liping Yang, Alexey Alekseev, Denice Hodgson-Zingman and Leonid Zingman

Molecular Therapy (2015) 23: 707–716; doi:10.1038/mt.2015.21

In the Materials and Methods section under “Vivo-morpholino,” the amount of oligonucleotides was incorrectly described as 2 nmol/l in 50 µl normal saline (about 1 ng). The correct amount is 2 nmol in 50 µl normal saline (approximately 20 µg), split between 2-3 injections per muscle. The authors regret the error.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES